This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...